Expert Interview
A Second Opinion: Looking at the potential of Know Labs Non-Invasive Continuous Glucose Monitor
Ticker(s): KNWN, MDT, DXCM, ABTInstitution: University of Pittsburgh Medical Center
- Clinical Associate Professor of Medicine & Endocrinologist at UPMC
- Diabetes Clinical Unit Leader who sees 200+ patients with Type 1 Diabetes
- Clinical and Research Interest in diabetes technology and multidisciplinary modes of care
Please describe your background and practice setting
Added By: ben_adminHow many patients with diabetes do you currently manage?
Added By: ben_adminHow many of your diabetes patients utilize CGMs?
Added By: ben_adminWhat are the different CGM brands available currently?
Added By: ben_adminHow beneficial would a non-invasive CGM be to patients?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
